NCT07617805
- Conditions
- Biomarker-positive EGFR/HER2- Expressing HNSCC, Carcinoma, Carcinoma, Squamous Cell, +11 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Biomarker-positive EGFR/HER2- Expressing HNSCC
Explore clinical trials studying Biomarker-positive EGFR/HER2- Expressing HNSCC. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study